These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20380588)

  • 1. Structural, cellular, and molecular evaluation of bone erosion in experimental models of rheumatoid arthritis: assessment by μCT, histology, and serum biomarkers.
    Chao CC; Chen SJ; Adamopoulos IE; Judo M; Asio A; Ayanoglu G; Bowman EP
    Autoimmunity; 2010 Dec; 43(8):642-53. PubMed ID: 20380588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
    Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP
    Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells protect from local and systemic bone destruction in arthritis.
    Zaiss MM; Frey B; Hess A; Zwerina J; Luther J; Nimmerjahn F; Engelke K; Kollias G; Hünig T; Schett G; David JP
    J Immunol; 2010 Jun; 184(12):7238-46. PubMed ID: 20483756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological characterization of receptor activator of NFkappaB ligand (RANKL) and IL-1beta expression in rodent collagen-induced arthritis.
    Weiss RJ; Erlandsson Harris H; Wick MC; Wretenberg P; Stark A; Palmblad K
    Scand J Immunol; 2005 Jul; 62(1):55-62. PubMed ID: 16092922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
    van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
    Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis.
    Schopf L; Savinainen A; Anderson K; Kujawa J; DuPont M; Silva M; Siebert E; Chandra S; Morgan J; Gangurde P; Wen D; Lane J; Xu Y; Hepperle M; Harriman G; Ocain T; Jaffee B
    Arthritis Rheum; 2006 Oct; 54(10):3163-73. PubMed ID: 17009244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458.
    Hannig G; Bernier SG; Hoyt JG; Doyle B; Clark E; Karp RM; Lorusso J; Westlin WF
    Arthritis Rheum; 2007 Mar; 56(3):850-60. PubMed ID: 17328059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erosive arthritis.
    Schett G
    Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S2. PubMed ID: 17634141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis: inflammation and bone loss.
    Schett G
    Wien Med Wochenschr; 2006 Jan; 156(1-2):34-41. PubMed ID: 16465612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory cells and bone loss in rheumatoid arthritis.
    Haynes DR
    Arthritis Res Ther; 2007; 9(3):104. PubMed ID: 17601357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone and joint destruction in rheumatoid arthritis: what is really happening?
    Goldring SR
    J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.
    Francis MD; Hovancik K; Boyce RW
    Int J Tissue React; 1989; 11(5):239-52. PubMed ID: 2517540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.
    Jimi E; Aoki K; Saito H; D'Acquisto F; May MJ; Nakamura I; Sudo T; Kojima T; Okamoto F; Fukushima H; Okabe K; Ohya K; Ghosh S
    Nat Med; 2004 Jun; 10(6):617-24. PubMed ID: 15156202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
    Stolina M; Adamu S; Ominsky M; Dwyer D; Asuncion F; Geng Z; Middleton S; Brown H; Pretorius J; Schett G; Bolon B; Feige U; Zack D; Kostenuik PJ
    J Bone Miner Res; 2005 Oct; 20(10):1756-65. PubMed ID: 16160733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
    J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
    Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
    J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
    Konda VR; Desai A; Darland G; Bland JS; Tripp ML
    Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.